Related Experiment Video
Updated: Jul 10, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Right ventricular thrombus with Behçet's syndrome: successful treatment with warfarin and immunosuppressive agents
Sait M Dogan1, Alparslan Birdane, Cengiz Korkmaz
1Department of Cardiology, SSK Region Hospital, Eskisehir, Turkey. smdogan@yahoo.com
Insights
Behçet
Area of Science:
- Cardiology
- Rheumatology
- Internal Medicine
Background:
- Behçet's syndrome is a rare chronic multisystem disorder.
- Cardiac involvement is an extremely rare manifestation of Behçet's syndrome.
Observation:
- A 33-year-old male patient with Behçet's syndrome presented with cough, fever, chest pain, hemoptysis, and weight loss.
- Echocardiography revealed a right ventricular thrombus.
Findings:
- The intracardiac thrombus in the right ventricle resolved after 1 month of treatment.
- Treatment included warfarin, cyclophosphamide, and corticosteroids.
Implications:
- This case highlights the importance of considering cardiac involvement in Behçet's syndrome.
- Early diagnosis and comprehensive treatment are crucial for managing rare cardiac manifestations.
Abstract:
Behçet's syndrome is a chronic multisystem disease that presents with recurrent oral and genital ulceration and recurrent uveitis. Cardiac involvement is an extremely rare manifestation of this disorder. A 33-year-old man with Behçet's syndrome was admitted to our department with a history of cough, fever, chest pain, hemoptysis, and weight loss. Transthoracic and transesophageal echocardiography revealed a right ventricular thrombus. After 1 month of treatment with warfarin, cyclophosphamide, and corticosteroid, the intracardiac thrombus resolved.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Endocarditis III: Medical Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction
Myocarditis III: Medical Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
